SCHEMBL5166098

SCHEMBL5166098

N#Cc1cccc(NOC(=O)Cc2ccccc2)c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.65
SMN1; SMN2 Q16637 2/20 0.48
MAPK1 P28482 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
PPIA P62937 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
FAAH O00519 1/20 0.46
CNR1 P21554 1/20 0.45
KCNA5 P22460 1/20 0.45
GRM4 Q14833 1/20 0.44
CCR3 P51677 2/20 0.43
HDAC4 P56524 1/20 0.42
MEF2D Q14814 1/20 0.42
VNN1 O95497 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4414928 0.81 ALDH1A1 (0.53) LMNASMN1; SMN2MAPK1L3MBTL1ALDH1A1
SCHEMBL29767752 0.79 LMNA (1.00) LMNASMN1; SMN2MAPK1HSD17B10L3MBTL1
SCHEMBL11668010 0.75 MEN1 (0.40) LMNAMAPK1HTTALDH1A1MAPT
SCHEMBL2662070 0.74 ERCC1 (0.52) LMNAALDH1A1CNR1VNN1
SCHEMBL8113690 0.74 LMNA (0.55) LMNASMN1; SMN2MAPK1HSD17B10L3MBTL1
SCHEMBL14867133 0.73 MGLL (0.67) LMNASMN1; SMN2MAPK1HSD17B10L3MBTL1
SCHEMBL27570584 0.72 HTT (0.50) LMNASMN1; SMN2MAPK1HSD17B10L3MBTL1
SCHEMBL27710783 0.71 KMT2A (0.44) LMNASMN1; SMN2MAPK1HSD17B10L3MBTL1
SCHEMBL1515919 0.71 GSK3B (0.64) LMNASMN1; SMN2L3MBTL1MAPTKMT2A
SCHEMBL27570585 0.70 KMT2A (0.54) LMNAL3MBTL1HTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
CN-1582148-A Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu MERCK PATENT GMBH (DE) 2005-02-16 CN disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed
EP-1351938-A1 PHENYL DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-15 EP disclosed
WO-2002057236-A1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 LMNA 2132/4885SMN1; SMN2 3430/4885MAPK1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.